drugset / Trial / NCT02456038
Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)
Phase 2
Completed
13 enrolled
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Osaka University Graduate School of Medicine · collab
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to assess safety and efficacy of Asfotase Alfa (ALXN1215) in patients with hypophosphatasia
Timeline
- Start
- 2014-08
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | asfotase alfa | Protein / enzyme biologic | 6 mg/kg | — |